iBio, Inc.
IBIO
$0.818
$0.0253.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.13M | -19.30M | -23.15M | -24.91M | -23.16M |
| Total Depreciation and Amortization | 848.00K | 1.19M | 1.22M | 1.26M | 1.27M |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 30.00K | 120.00K | 202.00K |
| Total Other Non-Cash Items | 5.74M | 5.03M | 7.84M | 8.14M | 3.95M |
| Change in Net Operating Assets | -2.90M | -3.00M | -2.87M | -3.17M | -930.00K |
| Cash from Operations | -12.44M | -16.09M | -16.93M | -18.55M | -18.67M |
| Capital Expenditure | -211.00K | -211.00K | -210.00K | -210.00K | -506.00K |
| Sale of Property, Plant, and Equipment | 66.00K | 66.00K | 66.00K | 116.00K | 550.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 712.00K | 1.71M | 1.71M | 1.00M | 1.00M |
| Cash from Investing | 567.00K | 1.57M | 1.57M | 906.00K | 1.04M |
| Total Debt Issued | 0.00 | 895.00K | 895.00K | 895.00K | 895.00K |
| Total Debt Repaid | -1.58M | -1.72M | -1.66M | -2.03M | -1.69M |
| Issuance of Common Stock | 14.25M | 18.53M | 22.63M | 25.64M | 15.04M |
| Repurchase of Common Stock | 0.00 | 0.00 | -7.00K | -7.00K | -7.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.00K | -1.00K | -1.00K | -1.00K | 0.00 |
| Cash from Financing | 12.68M | 17.70M | 21.86M | 24.49M | 14.24M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 33.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 807.00K | 3.18M | 6.50M | 6.85M | -3.35M |